Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Intellia Therapeutics Inc buy DomRuinart

Start price
€69.62
06.04.21 / 50%
Target price
€80.00
06.04.22
Performance (%)
-17.38%
End price
€57.52
19.04.21
Summary
This prediction ended on 19.04.21 with a price of €57.52. The prediction for Intellia Therapeutics Inc disappointed with a performance of -17.38%. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Intellia Therapeutics Inc 0.479% 0.479% -43.693% -84.255%
iShares Core DAX® 1.395% -0.696% 15.472% 15.907%
iShares Nasdaq 100 2.287% 7.501% 34.748% 53.474%
iShares Nikkei 225® 1.617% 2.769% 11.442% 8.194%
iShares S&P 500 0.659% 4.280% 26.778% 45.322%

According to DomRuinart what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -17.38%
Target price 80.000
Change
Ends at 06.04.22

Buy mit Kursziel 80,0

In the thread Trading Intellia Therapeutics Inc
Prediction Buy
Perf. (%) -17.38%
Target price 80.000
Change
Ends at 06.04.22

Buy beendet

Stopped prediction by DomRuinart for Intellia Therapeutics Inc

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€53.20
24.03.21
€60.00
24.03.22
30.86%
06.04.21

Could be worthwhile Investment >10% per year